Clinical Trial Update: A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial compared trabectedin to dacarbazine in patients with advanced liposarcoma or leiomyosarcoma; results were posted in January 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Liposarcoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Trabectedin (trabectedin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Advanced Liposarcoma or Leiomyosarcoma | Phase 3 | Status: COMPLETED | Results posted: 2016-01-28